Safety and Efficacy of Epicardial Implantation of Collagen Membranes With Allogeneic Adipose Derived Stem Cells

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
CABG-patientsHeart FailureMyocardial Infarction (MI)
Interventions
COMBINATION_PRODUCT

VB-C01 cellularised patch

surgical epicardial implantation of a membrane seeded with allogeneic adipose tissue derived stem cells in patients scheduled to undergo coronary revascularisation surgery and at high risk of developing heart failure

Trial Locations (1)

40-635

Górnośląskie Centrum Medyczne im. prof. Leszka Gieca Śląskiego Uniwersytetu Medycznego w Katowicach, Katowice - Ochojec

All Listed Sponsors
collaborator

KCRI Sp. z o.o.

UNKNOWN

collaborator

Medical University of Silesia

OTHER

collaborator

Clinica Universidad de Navarra, Universidad de Navarra

OTHER

collaborator

Hospital General Universitario Gregorio Marañon

OTHER

lead

Viscofan

INDUSTRY

NCT06956807 - Safety and Efficacy of Epicardial Implantation of Collagen Membranes With Allogeneic Adipose Derived Stem Cells | Biotech Hunter | Biotech Hunter